ACE and obesity due to melanocortin 4 receptor deficiency: The link between LE and ACE expression levels and LE as an ACE inhibitor also provides a mechanism based upon which LE is not only useful in the management of obesity but could also be beneficial in the management of cardiovascular diseases.